Some eyedrops have led to death and eyeball removal in USA


Photo by Ion Fet on Unsplash

The US Centers for Disease Control and Prevention (CDC) has identified a rare strain of Pseudomonas aeruginosa as the likely culprit behind a recent outbreak of infections linked to eyedrops.

The CDC has found that 68 patients across 16 states have contracted the bacterial infection, with one person reported dead and several others suffering severe injuries, including vision loss and the removal of an eye.

Most of the patients diagnosed with the infection reported using eyedrops and artificial tears, leading the CDC to investigate the potential contamination of these products.

The outbreak strain has never been found in the US before, and ten different brands of eyedrops were initially identified as possibly linked to the outbreak.

Eyedrops manufactured in India and imported to the US under two brands were subsequently pulled from shelves in January and February after testing revealed that opened bottles taken from patients were contaminated with the bacteria.

Unopened bottles are currently being tested to determine whether contamination occurred during the manufacturing process.

The CDC has warned against using EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears since January, and the company that owns these brands, Global Pharma, issued a voluntary recall the following month.

Last week, a woman in Florida filed a lawsuit against the drug company, claiming that the infection she suffered after using their product forced doctors to remove one of her eyes.

The cause of the contamination is still under investigation, but a lawyer for the woman who filed the lawsuit has blamed a lack of preservatives in the eyedrops.

The CDC advises anyone experiencing eye-related symptoms after using eyedrops or artificial tears to seek medical attention immediately.